Before you leave...
Take 20% off your first order
20% off
Enter the code below at checkout to get 20% off your first order
Discover summer reading lists for all ages & interests!
Find Your Next Read
The complete immunotherapy reference from basic science to clinical application
Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single resource has unified its foundational immunology with advanced clinical applications. Frazer's Foundations of Immunotherapy addresses this absence, offering comprehensive coverage co-edited by Fernando Guimaraes, a leading immunotherapy expert and Ian Frazer, co-developer of the HPV vaccine Gardasil. With coverage of CAR T-cell therapy, NK cell therapies, precision immunotherapy, and the microbiome's role in treatment response, this text integrates evolving research with practical protocols for students, researchers, and clinicians.
Readers will also find:
This guide will benefit advanced students in biomedical and medical programs, immunology and oncology professionals, biotechnology researchers, and clinical trainees. Frazer's Foundations of Immunotherapy provides the structured pathway from fundamental principles to therapeutic applications that this rapidly evolving field demands.
Author: Fernando Guimaraes
ISBN-10: 1394383010
ISBN-13: 9781394383016
Publisher: Wiley
Language: English
Published: 08/07/2026
Pages: 416
Format: Paperback
Weight: 1.59lbs
Size: 10.00h x 7.00w x 0.85d
Fernando S. F. Guimaraes is a Group Leader at The University of Queensland's Frazer Institute, leading research on next-generation immunotherapies for hard-to-cure diseases. With over 120 publications in top-tier journals and NHMRC and MRFF funding, he earned the 2019 Cure Cancer Australia Researcher of the Year award and the 2025 Dr. Jian Zhou Foundation Award for Translational Medicine.
Ian Frazer is Emeritus Professor at The University of Queensland's Frazer Institute and co-developer of the HPV vaccine Gardasil, which has greatly reduced cervical cancer rates worldwide. Named Australian of the Year in 2006 and appointed Companion of the Order of Australia in 2012, he served as founding CEO of Brisbane's Translational Research Institute.
Thanks for subscribing!
This email has been registered!
Take 20% off your first order
Enter the code below at checkout to get 20% off your first order